Goldman Sachs Starts Abivax (ABVX) at Buy, 'screens well as a potential M&A target'
Tweet Send to a Friend
(Updated - September 10, 2026 5:57 AM EDT)
Goldman Sachs analyst Rajan Sharma initiates coverage on Abivax (NASDAQ: ABVX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Goldman Sachs analyst Rajan Sharma initiates coverage on Abivax (NASDAQ: ABVX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
